RedHill Biopharma Ltd. (RDHL)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$0.82
-11.51%
Mkt Cap $3.08M
No analyst coverage available
We don't have analyst ratings or price target data for RedHill Biopharma Ltd. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.